GL1X · GenesisL1 explorer

MolNFT v1 · #140719 · protein

Crystal structure of SMYD3 in complex with covalent inhibitor 4

5YJO · Histone-lysine N-methyltransferase SMYD3: “Crystal structure of SMYD3 in complex with covalent inhibitor 4”. X-ray diffraction, 3 ligands (8W0, SAM, ZN), 3 pockets (best druggability 0.79). MolNFT v1 #140719 on GenesisL1: 3D…

PDB
5YJO
Type
protein
Length
423 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Histone-lysine N-methyltransferase SMYD3
EC
2.1.1.43
UniProt
Q9H7B4
Ligands
8W0, SAM, ZN
Pockets
3 · best druggability 0.79

Structure

x-ray diffraction · 1 distinct chain · 50% helix, 13% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHistone-lysine N-methyltransferase SMYD3 (EC 2.1.1.43)protein42350% helix, 13% strandQ9H7B4

Ligands and binding sites

  • 8W0 · propyl (3~{S})-4-[[(6~{R})-6-(aminomethyl)-5,6,7,8-tetrahydroacridin-3-yl]carbonyl]-3-methyl-piperazine-1-carboxylate · ligand · chains A
  • SAM · S-adenosylmethionine · ligand · chains A
  • ZN · Zinc ion · metal · 3 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110900.790.811018W0, SAM
21950.540.7834empty
31010.440.7926empty

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 5YJO · Crystal structure of SmyD3 in complex with covalent inhibitor 4 · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9H7B4 · AlphaFold monomer V2.0 prediction for histone-lysine N-methyltransferase SMYD3 (Q9H7B4) · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.